MMP9 and chronic kidney disease: Given that increases in MMP-2 and MMP-9 activity may exacerbate arterial stiffening in the setting of vascular inflammation, these data suggest a possible anti-inflammatory and protective role for calcitriol and paricalcitol in muscular artery in the context of CKD.